6 days ago ... Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability case filed on February 15, 2019 in the New Jersey District Court.
Aug 2, 2017 ... 3:17-00240. District of Idaho. BUZBEE v. ASTRAZENECA PHARMACEUTICALS LP, ET AL., C.A. No. 3:17-00174. Central District of Illinois.
Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...
May 2, 2017 ... ASTRAZENECA PHARMACEUTICAL LP ASTRAZENECA LP. ... TAYMARI DELGADO ECHEVARRÍA, Plaintiff, Appellant, v. ... As in all other summary- judgment cases, we view the facts (and all reasonable inferences that can ...
Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
May 22, 2018 ... Specifically, the record revealed that the firm engineered the switch from .... 39 See Mansfield et al., supra note 15; see also Walgreen Co. v. .... Alexander & Randall S. Stafford, Does Comparative Effectiveness Have a Comparative Edge? , ...... the representative claim at issue in AstraZeneca AB v. Anchen.
Healing rates were similar across all esomeprazole dose groups. .... from AstraZeneca LP) for study leadership and project management, respectively; ... Ravelli AM, Villanacci V, Ruzzenenti N, et al. ... Winter HS, Madara JL, Stafford RJ, et al.
No effect58. Decrease in glucagon vs BL ..... et al167 found that dapagliflozin induced glucosuria and improved peripheral insulin sensitivity ...... mington, DE: AstraZeneca Pharmaceuticals LP; 2015. 93. ... Stafford S, Elahi D, Meneilly GS.